Lucid Diligence Brief: Novo Nordisk to acquire Akero Therapeutics for up to $5.2 billion
Lucid Diligence Brief: Novo Nordisk to acquire Akero Therapeutics for up to…
Obesity Weekly News - September 29th 2025
Obesity Update: Pfizer–Metsera Acquisition, Lilly’s $6.5B API Expansion, &…
Obesity Weekly News - September 16th 2025
Obesity Update: ASC30’s Ultra-Long Dosing, Oral GLP-1 Pill Race, Korea…
Cardiovascular Weekly News - September 4th 2025
Cardiovascular Update: AI Targets VT, Evolocumab Approved, Wegovy Cuts Heart…
Obesity Weekly News - September 2nd 2025
Viking’s Crash, Orforglipron’s Big Win, Wegovy vs Tirzepatide, Saxenda Generic…
Obesity Weekly News - August 26th 2025
Viking’s Crash, Orforglipron’s Rise, Semaglutide CV Data, SlimBiome Deal &…
Obesity Weekly News - August 19th 2025
Obesity Update: Enobosarm’s Oral Release, AI-Powered Drug Discovery, £85M…
Obesity Weekly News - August 5th 2025
Obesity Update: Radella’s MD-18, Korglutide’s Oral Entry, Liraglutide Launches,…
Obesity Weekly News - July 29th 2025
Obesity Update: Once-Monthly ASC30 Trial, Viking’s Phase III Launch, Generic…
Obesity Weekly News - July 15th 2025
Obesity Update: Wegovy’s 7.2mg Bid, Rhythm’s Oral Win, TRPV1 Breakthrough &…
Public Health Weekly News - June 13th 2025
Discover the latest breakthroughs in Public Health—from fertility and cancer…
Obesity Weekly News - May 6th 2025
Obesity Latest News: GLP-1 Pill Update, Discount Wars & Pharma Shakeups In…